![]() |
NDA |
ISIN | DE0006766504 |
Security | NDA |
Exchange | EUREX |
Type | Option |
Options
Exp. date | Type | Type |
---|---|---|
3/21 | 58 Calls | 57 Puts |
4/21 | 31 Calls | 31 Puts |
5/21 | 27 Calls | 27 Puts |
6/21 | 29 Calls | 28 Puts |
9/21 | 19 Calls | 19 Puts |
12/21 | 25 Calls | 25 Puts |
6/22 | 16 Calls | 16 Puts |
12/22 | 16 Calls | 16 Puts |
6/23 | 10 Calls | 10 Puts |
12/23 | 15 Calls | 15 Puts |
12/24 | 15 Calls | 15 Puts |
12/25 | 9 Calls | 9 Puts |
News
- CorMedix Inc. to Host Regulatory Update Conference Call
23:00 - GlobeNewswire - ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athenex, Inc. Investors to Secure Counsel Before Important Deadline – ATNX
22:58 - GlobeNewswire - Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
14:00 - GlobeNewswire - Minerva Neurosciences Reports Fiscal 2020 Fourth Quarter and Year End Financial Results and Business Updates
13:30 - GlobeNewswire - Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus
07:00 - GlobeNewswire